Leslie Trigg
CIK 1304125 · Chair and CEO · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.71M
Companies
5
Total Filings
105
Lifetime Open-Market Net
-$30.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OM | Chair and CEO | 239,700 | $4.72 | $1.13M | -$30.45M | 61 | 2026-06-29 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 13,925 | $104.91 | $1.46M | $0 | 3 | 2026-03-23 |
| ARYA Sciences Acquisition Corp IV (ARYD) Delisted | Director | — | $6.64 | — | $0 | 1 | 2024-07-31 |
| ADPT | Director | 25,907 | $22.52 | $583.4K | $0 | 3 | 2023-03-08 |
| Cardiovascular Systems Inc (CSII) Delisted | Director | 17,282 | $20.00 | $345.6K | -$326.4K | 12 | 2016-11-21 |
Recent Filings · Page 2 of 11
105 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-07 | OM | Notice (144) | −1,795 | -$7.7K | EDGAR |
| 2025-11-18 | OM | Sell (S) | −916 | -$4.2K | EDGAR |
| 2025-11-17 | OM | Notice (144) | −916 | -$4.2K | EDGAR |
| 2025-08-18 | OM | Sell (S) | −904 | -$11.6K | EDGAR |
| 2025-08-15 | OM | Notice (144) | −904 | -$11.6K | EDGAR |
| 2025-06-16 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +7,670 | $0 | EDGAR |
| 2025-06-11 | OM | Grant (A) | +65,103 | $0 | EDGAR |
| 2025-05-16 | OM | Sell (S) | −935 | -$16.6K | EDGAR |
| 2025-05-15 | OM | Notice (144) | −935 | -$16.6K | EDGAR |
| 2025-05-01 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +8,527 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.